Previous Close | 44.65 |
1-Year Change | -21.68% |
6-Months Change | -12.47% |
3-Months Change | -6.59% |
Moving Avg (50d) | 45.316 |
Moving Avg (200d) | 52.998 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 2.73B |
Beta (3-Years) | 1.48 |
Revenue Growth (ttm) | 13.59% |
Net Profit Margin (ttm) | -6.09% |
Return On Assets (ttm) | -1.25% |
EPS (ttm) | -0.52 |
PE Ratio (ttm) | -85.87 |
Dividend Yield | % |
Asset Description: | Azenta, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-14 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
46.441 | 47.806 | 48.717 | 50.083 | 52.359 | 54.636 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Health Care Supplies |
Country: | United States |
Azenta was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics. Wikipedia